Raising heart-healthy children by Rocchini, Albert P.
Coronary artery disease has its origin in childhood.1,2
Epidemiological and clinical studies in adults with coronary
heart disease have made it possible to develop lists of risk
factors that can help to identify individuals susceptible to the
development of coronary heart disease. The risk factors that
have been identified include obesity, increased blood
pressure, hyperlipidemia, cigarette smoking, poor physical
fitness and prenatal environment. The current article will
describe how these risk factors impact the development of
cardiovascular disease and what types of therapy can be
used in the pediatric patient to modify them.
Obesity
Obesity is a complex and difficult clinical problem. It is the
most prevalent and serious nutritional disease in the
developed world. Childhood obesity is known to exert a
major impact on cardiovascular risk. We have documented
that 97% of obese children have four or more of the
following risk factors: elevated blood pressure, elevated
serum triglyceride levels, decreased high density lipoprotein
(HDL) cholesterol levels, increased total cholesterol levels,
diminished work capacity, hyperinsulinemia, insulin
resistance and a strong family history of coronary heart
disease.3 For over 70 years, it has been recognized that
hypertension is common in obese individuals. We have
observed that obese adolescents have a blood pressure
distribution that is skewed to the right.4 The mean blood
pressure for the group is greater than one standard deviation
to the right of the mean blood pressure for the general
population. We have also demonstrated that although obese
adolescents have a blood pressure distribution that is skewed
to the right of normal, following weight loss this distribution
no longer differs from the general population.4 In the same
study, we also demonstrated that the method by which
weight loss is produced was important in determining the
degree of blood pressure reduction. Although weight loss in
general results in a drop in resisting systolic and diastolic
blood pressure and heart rate, the greatest decrease in resting
systolic blood pressure and heart rate is observed when
weight loss is incorporated with physical conditioning.
Another major cardiovascular risk factor associated with
obesity is an abnormal lipid profile.5 When children and
adult subjects are stratified for fatness, there is a direct
significant relationship between lipid levels and obesity. The
primary cause of hypertriglyceridemia in children who are
free from other diseases is obesity. In addition, obesity is
frequently associated with a significant depression in HDL
cholesterol. We have demonstrated that, as with blood
pressure, lipid abnormalities are markedly improved in
obese adolescents following weight loss and that a weight-
loss program that incorporates exercise along with caloric
restriction produces the most favorable effects on lipids.4 We
and others have determined that the lipid abnormalities
observed in obese adolescents are directly associated with
hyperinsulinemia and insulin resistance.5 Insulin resistance,
in our study, was assessed in obese adolescents by
measuring both fasting insulin and whole body glucose
uptake during euglycemic hyperinsulinemia clamp. Using a
step-wise multiple regression analysis, we have documented
that whole body glucose uptake, that is, insulin sensitivity,
was the most important determinant for triglyceride level,
low density lipoprotein (LDL) and HDL cholesterol in our
obese patients. Fasting insulin level was also directly
correlated to total cholesterol and inversely to HDL
cholesterol level. The mechanism whereby insulin resistance
leads to these lipid abnormalities has not been completely




CS Mott Hospital, University of Michigan Medical Center, Ann Arbor, Michigan, USA
Abstract The current article will describe how the cardiovascular risk factors of obesity, increased blood pressure,
hyperlipidemia, cigarette smoking, poor physical fitness and prenatal environment impact the development of
cardiovascular disease and what types of therapy can be used in the pediatric patient to modify them.
Key words childhood smoking, cholesterol, hypertension, obesity, perinatal cardiovascular risk.
Correspondence: Albert P Rocchini, CS Mott Hospital, University
of Michigan Medical Center, Box 0204, Ann Arbor, MI 48109,
USA. Email: <rocchini@umich.edu>
Received 24 April 1999.
characterized. There is evidence to suggest that two of the
ways in which hyperinsulinemia elevates triglycerides are
through enhanced hepatic very low density lipoprotein
synthesis and through a defect in very low density lipo-
protein (VLDL) removal. An increased rate of degradation
of the apoprotein A1 (the major lipoprotein in HDL
cholesterol) is believed to be a major cause for the reduced
level of HDL cholesterol observed in many insulin-resistant
subjects.
Another important cardiovascular risk factor that we have
found associated with obesity is the development of cardiac
hypertrophy. We have observed that, compared to non-obese
adolescents, obese adolescents have a significant increase in
left ventricular mass (Fig. 1). The increase in left ventricular
mass is probably the result of the elevated blood pressure
and the increased cardiac output and stroke volume that
accompany obesity.
Treatment modalities used in obese children and
adolescents can be characterized into one of a combination
of six basic approaches: (i) caloric restriction; (ii) increase
physical activity; (iii) habit pattern changes based on social
learning theory; (iv) anoretic drugs; (v) therapeutic
starvation; and (vi) intestinal bypass surgery. Certainly, drug
therapy, starvation and surgery are unacceptable treatment
strategies for the majority of children. However, a practical
weight-loss program can be developed for the child. We
believe that in order to assess the child’s ability to comply
with a weight-loss program, it is advisable to use a trial diet
for 2–3 weeks. If the child is successful with this diet, that
is, losing at least 0.5–1 kg in 2–3 weeks, he or she is likely
to benefit from a weight-loss program. If, however, the child
is unsuccessful, the family and child should be counselled
and asked to return in 3–6 months or sooner if there is a
change in attitude towards a weight-loss program. The
weight-loss program that we use consists of three
components: (i) diet; (ii) behavior change; and (iii) exercise.
The caloric requirements necessary for a child to lose
0.5–1 kg per week are determined by reducing the current
level of calories by 209–419 J/day. We believe that an
adolescent weight-reduction diet should not contain less than
5013 J/day, because if diet is more deficient in kilojoules
than this then it may provide inadequate vitamins and
nutrients to promote normal growth and development.
However, kilojoule levels should never exceed 10 443 J/day,
because the child is unlikely to take the diet seriously if
allowed too large a caloric intake. An exchange-type diet is
our best recommendation, because it teaches the child the
essentials of good nutrition and gets them actively involved
in determining their own diet. The behaviour change
component of the program includes hourly classes that are
maintained weekly for at least 20–30 weeks and then every
other week until the child has maintained a goal weight for
at least 1 month. These classes center on nutrition education,
record keeping, stimulus control for restricting the external
cues that set the occasion for eating and reinforcement of
altered behaviour. The purpose of the behaviour change
component is to help the obese child learn to eat like a non-
obese person, to become aware of current habits, to
normalize and accept responsibility for their eating
behaviour. Finally, all children are encouraged to exercise
for 30–60 min/day for at least 3 days/week. In addition to
the child-structured portion of the program, family support is
critical. The family needs to be taught how to give the child
positive support without nagging or taking over the child’s
weight-loss program. Using this type of program, we have
been able to achieve adequate weight loss in adolescents
who are motivated to lose weight. When dealing with
childhood obesity, one must always remember that if the
child or adolescent does not want to lose weight then no
weight loss program, regardless of its approach, organization
or cost, will be successful.
Hypertension
During the past 20 years, it has become increasingly clear
that hypertension constitutes a major disease process in
adolescents as well as adults. The incidence of hypertension
in the pediatric population varies from 0.5 to 11%,
depending upon the age group investigated and the criteria
used to define hypertension. Using the standard blood
pressure tables for age, gender and weight, normal blood
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Fig. 1 Comparison of left ventricular (LV) mass determined
by echocardiogram from 55 obese and 45 non-obese adoles-
cents. The obese adolescents have a significantly increased LV
mass (*P<0.001).
pressure is defined as a systolic and diastolic blood pressure
that is less than the 90th percentile, whereas elevated blood
pressure is a blood pressure that is above the 90th percentile
rank for age and sex.6 The definition of hypertension is
reserved for those individuals that have a blood pressure that
is abnormal, greater than the 90th percentile for age and sex,
on at least three separate examinations over 6–12 months
intervals, if not associated at the time of the initial
examination with signs and symptoms found with hyper-
tensive cardiovascular disease (myocardial hypertrophy,
papilledema, persistent headaches, blurred vision, coma,
convulsion etc.). As with adult hypertension, the majority of
children with high blood pressure have essential hyper-
tension. We have evaluated 120 consecutive children referred
for evaluation of hypertension. In this group of children,
59% had essential and 41% had secondary causes for the
hypertension. The types of secondary hypertension in our
children were: (i) renal causes in 70%; (ii) cardiac causes in
20%; (iii) endocrine causes in 8%; and (iv) other causes in
the remaining 2%. Of the patients with essential hyper-
tension, over 75% of them were overweight.
The management of high normal or high blood pressure
without an identifiable cause includes: (i) weight reduction if
the child is obese; (ii) exercise; (iii) moderate salt
restrictions; (iv) avoiding the use of tobacco; and (v) avoiding
cigarette smoking. For patients with severe elevations of
blood pressure, pharmacologic therapy may often be
required. Pharmacologic therapy is indicated in children with
severe hypertension (that is, blood pressures greater than the
95th percentile for age and sex), children with significant
hypertension (greater than the 90th percentile) who are
unresponsive to non-pharmacological therapy and children
with significant hypertension associated with end-organ
damage. In the past, diuretics and beta blockers were the
initial steps of therapy for the hypertensive child; however,
we believe that the first-line therapy of a child with hyper-
tension should be angiotensin I converting enzyme (ACE)
inhibitors or calcium channel blockers. Because of side-
effects (alterations in glucose, lipid metabolism and
depression), diuretics and beta blockers should be used as
second-line therapy. The other new agents in the
management of hypertension are alpha blockers and the
combined alpha beta adrenergic receptor blocker, Labetalol.
Hyperlipidemia
Hyperlipidemia is known to be an important risk factor for
the development of adult-onset heart disease. In order to
understand abnormalities of lipid metabolism and their
treatment, it is important to understand the process by
which the body handles cholesterol. The three major
sources of cholesterol are intracellular production, dietary
fat and recycling of cholesterol through the gastrointestinal
pathway. Dietary fat that is digested and absorbed is
reprocessed in the liver. The liver then secretes the
reprocessed fats either into the intestine, as bile acids, or
into the blood stream in combination with triglycerides as
VLDL particles. The VLDL particles are converted in the
plasma to LDL, which can then be taken up by the cells and
reconverted into cholesterol. The LDL particles are guided
by apoproteins (lipoproteins surface proteins) to the LDL
receptor sites on the cell. The number of LDL receptors and
their affinity for apoproteins determines the level of
cholesterol in the body. The cell prefers to use exogenous
cholesterol rather than to manufacture its own cholesterol.
This preferential usage depends on a biochemical feedback
system, whereby raising intracellular cholesterol levels
reduces cholesterol production by inhibiting the rate
limiting enzyme 3-hydroxy 3-methylglutaryl coenzyme A
(HMG CoA) reductase and by activation of the enzyme
acylcoenzyme A transferase (ACAT), which esterifies
cholesterol for storage. Increased intracellular cholesterol
also reduces cellular LDL cholesterol uptake by blocking
formation of LDL receptors and by inhibiting LDL receptor
gene expression. Intracellular cholesterol that is not used or
stored by the cell is passed out of the cell. Some of the
excess cholesterol combines with recycled LDL particles to
form HDL particles. These HDL particles eventually are
removed from the circulation by the liver. The formation of
HDL cholesterol is the major means by which excess
cholesterol is removed from the cells. Abnormalities in the
method by which the cell handles LDL receptor formation
is the cause of one of the most common genetic forms of
hyperlipidemia, familial hypercholesterolemia. In this
disease there is an alteration in either the number or the
function of the LDL receptors leading to a reduced binding
of LDL cholesterol to the receptors, a higher serum LDL
cholesterol concentration, a higher plasma cholesterol level
and atherogenesis.
Most individuals with hyperlipidemia are asymptomatic.
The only pertinent physical findings or symptoms
associated with hyperlipidemia include: (i) a history of
abnormal glucose tolerance or hyperuricemia (seen with all
types of hypertriglyceridemia); (ii) a history of xanthoma
(seen with familial hypercholesterolemia); and (iii) a history
of recurrent unexplained pancreatitis or abdominal pain
(seen with exogenous hyperchylomicronemia, familial
hypercholesterolemia or combined familial hyperlipidemia).
The major method for diagnosing hyperlipidemia is to
measure the concentration of the blood lipoproteins. Lipid
screening is currently recommended only if a child has a
history compatible with hyperlipidemia, consisting of the
above described physical findings and symptoms or a
family history of premature atherosclerotic disease (defined
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as appearance of clinical manifestations of atherosclerosis
prior to 50 years of age for men and 60 years in women).
Blood evaluation of lipids needs to be interpreted, as with
blood pressure, based on population norms.7 Traditional
values greater than the 90th percentile cut-offs have been
used for defining abnormal cholesterol and triglyceride
levels. For cholesterol, the 95th percentile for all ages and
sex is greater than 200 mg/dL and for triglyceride it is
greater than 115 mg/dL.
The cornerstone of lipid management, regardless of
cause, is diet. Both the saturated fat content and cholesterol
content of the diet must be reduced in order to obtain
maximum dietary benefit. Saturated fats appear to increase
the synthesis of LDL cholesterol and to decrease LDL
cholesterol disposal. Polyunsaturated fats decrease VLD
triglyceride, cholesterol and apoprotein B synthesis. Mono-
unsaturated fats (such as canola oil, olive oil, and peanut oil)
are especially beneficial, because they not only reduce LDL
cholesterol, but also reduce the LDL to HDL cholesterol
ratio. Other ways in which changes in diet can lower
cholesterol are to increase the intake of high fiber foods and
other water soluble fibers. Marine or omega-3 fatty acids
also can help reduce VLDL triglyceride levels, primarily by
decreasing VLDL synthesis. Dietary therapy, at best, will
only cause a 5–20% decrease in cholesterol. However, it has
been our experience that classic dietary therapy, where the
index child is placed on a low cholesterol diet without
treating other family members, is doomed to failure.8
Because most lipid abnormalities are inherited, frequently in
an autosomal dominant fashion, if a child has an elevated
cholesterol one or both parents will also be found to have a
high cholesterol. We have recently compared the use of a
family focused therapy to standard dietary counselling. We
have found that compared to standard therapy, family
intensive therapy results in a significantly greater reduction
in total cholesterol and LDL cholesterol, not only in the
index case but also in other family members.8
The goal of therapy should be to reduce total cholesterol
below 200 mg/dL and LDL cholesterol below 120 mg/dL,
while maintaining HDL cholesterol levels greater than
40 mg/dL. If these goals cannot be reached by non-
pharmacological therapy alone, pharmacological agents 
need to be considered. Because pharmacological agents are
not without side-effects, most pediatric lipid specialists 
do not recommend adding lipid-lowering drugs unless dietary
means are unable to reduce total cholesterol below
250 mg/dL and LDL cholesterol below 175 mg/dL. The
current lipid-lowering drugs that are used in the pediatric
population include the bile acid resins, nicotinic acid, HMG
CoA reductase inhibitors (such as lovastatin, pravastatin, and
simvastatin) and gemfibrozil.
It is important to remember that, although there is now
increasing evidence in the adult, treatment of hyperlipidemia
can result in reduction of coronary mortality and even
regression of atherosclerotic lesions. Little to no data on the
efficacy of long-term treatment of mild to moderate elevated
cholesterol to prevent atherosclerosis later in life is available
in the pediatric population.
Smoking
Cigarette smoking is the major avoidable cardiovascular
risk factor.9 One of the most disturbing features about
smoking is that since 1964 more than 30 000 Americans
have stopped cigarette smoking, yet cigarette smoking has
not decreased in its prevalence among adolescent
populations. In fact, over the past 2–3 years, adolescent
cigarette smoking has actually increased. Adolescents
represent the largest group of individuals at risk to start
cigarette smoking. Smoking is known to increase
cardiovascular risk directly by altering blood pressure,
increasing total serum cholesterol levels and decreasing
HDL cholesterol levels. In addition, maternal smoking is
known to affect the fetus by interfering with fetal growth,
causing increased perinatal deaths and producing premature
delivery. The most effective way of treating smoking is
through its prevention. Because the incidence of smoking is
highest among adolescents, it is critical to prevent smoking
in this age group. Most studies suggest that a school-based
prevention program beginning in the 6th grade with booster
sessions throughout the remaining 6 years of secondary
education can result in a significant reduction in the
incidence of adolescents smoking.
Physical activity
A reduced amount of physical activity has been documented
to be an important cardiovascular risk factor. The amount of
exercise an individual regularly performs inversely
correlates with cholesterol and triglyceride levels and with
obesity. In a recent study of 200 boys and girls between the
ages of 12 and 17, the exercise time on the treadmill
indirectly related to their level of resting blood pressure and
their body mass index. That is, individuals whose exercise
endurance was less than the 5th percentile for their age and
sex almost uniformly had mild to moderate elevations in
blood pressure and had a body mass index that was greater
than 28 kg/m2 (Figs 2,3). Although it is clear in the adult
that physical activity can reduce coronary risk, there is little
to no information concerning the long-term effects of
childhood exercise programs in reducing the risks for
development of cardiovascular disease.
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Fig. 2 Relationship between exercise endurance (exercise
time) and body mass index (BMI) in 200 children who have
undergone a treadmill exercise test. The children whose exercise
endurance is less than the fifth percentile have a significantly
increased BMI. *P<0.01 compared with the 10–75 and >75
percentiles.
Fig. 3 Relationship between exercise endurance (exercise time)
and resting systolic blood pressure (SBP) in 200 children who
have undergone a treadmill exercise test. The children whose
exercise endurance is less than the fifth percentile have a
significantly increased resting SBP. *P<0.01 compared with
the 10–75 and >75 percentiles.
Table 1 Recommended cardiovascular health schedule
Birth
1. Obtain family history for early coronary artery disease and hyperlipidemia. If positive, introduce risk factors and parental referral.
2. Start growth chart.
3. Obtain parental smoking history and try to refer parents who are smoking for smoking cessation classes.
Age 0–2 years
1. Update family history and growth chart.
2. With introduction of solids, begin teaching regarding a healthy diet that is nutritionally adequate and low in salt and in saturated fats.
3. Recommend healthy snacks as ‘finger foods’.
Age 2–6 years
1. Update family history and growth chart. Review growth chart with family. Concept of weight for height should be introduced, trying
to identify children who are showing signs of obesity.
2. Change to a low-fat milk.
3. Start blood pressure chart at 3 years of age. Review the concept of lowering salt intake.
4. Encourage parent/child play that develops coordination and may produce a more permanent increase in lifestyle activity.
5. Obtain lipid determination in children with positive family history or with parental cholesterol exceeding 200 mg/dL (obtain parental
lipids if necessary and if lipid screening is abnormal initiate nutritional counselling).
Age 6–10 years
1. Update family history, blood pressure and growth charts.
2. Complete cardiovascular health profile with child. Obtain family history, smoking history, blood pressure percentile, weight for
height, measure cholesterol if indicated and determine level of cardiovascular fitness.
3. Reinforce a prudent diet that is low in fat and cholesterol. Begin antismoking counselling.
4. Introduce fitness for health, life sport activities for child and family.
5. Discuss role of TV watching and sedentary life style and obesity.
After 10 years of age
1. Update family history, blood pressure and growth charts annually. Review prudent diet, risks of smoking and fitness benefits
whenever possible.
2 Consider lipid profile in indicated patients.
3. Fitness review of personal cardiovascular health status.
Prenatal environment
Barker and coworkers have popularized the idea that factors
which disturb fetal development and/or growth can
profoundly influence postnatal outcome.10,11 In a study
recently published, Barker et al. have demonstrated that in
156 men born between 1907 and 1925, the death rate from
cardiovascular disease fell progressively with increasing
birth weight, head size and ponderal index.10 In another
study, they have demonstrated that death rates from
coronary artery disease are three-fold higher if weight was
less than 8.2 kg at the age of 1 year, compared with those
who weighed more than 12.3 kg at age 1.11 Barker has
suggested that increased cardiovascular risk is more
dependent on being born small for gestational age rather
than being born premature. The first person to suggest 
that maternal environment for the fetus may affect the long-
term outcome for cardiovascular risk was Freinkel in 1980,
who hypothesized the fuel-mediated teratogenesis theory.12
Barker has suggested that growth during critical periods of
early life may permanently affect the structure and
physiology of a range of organs, including the pancreas,
liver and blood vessels. For example, people who are thin at
birth tend to develop the combination of insulin resistance,
hypertension and non-insulin dependent diabetes, whereas
those who are short in relation to head size tend to develop
hypertension. Similarly, others have demonstrated that
offspring of diabetic mothers have an increased risk of
developing childhood obesity, impaired glucose tolerance
and diabetes in adolescence.13 Thus, many individuals have
suggested that normalization of maternal metabolism during
pregnancy may be a potent therapeutic and preventive
approach to the long-term prevention of premature
morbidity and mortality from atherosclerotic heart disease.
Summary
Because coronary artery disease has its origins in childhood,
it is critical that pediatricians become involved in the
identification and treatment of children at risk for early
development of cardiovascular disease. An appropriate
cardiovascular health schedule that all pediatricians should
be following is outlined in Table 1.
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